Skip to main content

Table 4 Abnormal LV geometry for the prediction of stroke/CHD and all-cause mortality at follow-up

From: Echocardiographic left ventricular geometry profiles for prediction of stroke, coronary heart disease and all-cause mortality in the Chinese community: a rural cohort population study

 

Stroke/CHD

All-cause mortality

Cases/Noncases

Incidence HR (95% CI)

P value

Cases/Noncases

Incidence HR (95% CI)

P value

Overall

      

 Normal geometry

336/7603

Reference

–

239/7700

Reference

–

 Concentric remodeling

73/686

1.42 (1.09, 1.84)

0.01

49/710

1.23 (0.89, 1.69)

0.21

 Concentric hypertrophy

67/359

1.39 (1.04, 1.86)

0.03

47/379

1.50 (1.07, 2.12)

0.02

 Eccentric hypertrophy

92/724

1.42 (1.11, 1.82)

 < 0.01

76/740

1.58 (1.19, 2.10)

 < 0.01

Male

      

 Normal geometry

183/3634

Reference

–

129/3688

Reference

–

 Concentric remodeling

40/289

1.39 (0.98, 1.99)

0.07

29/300

1.50 (0.99, 2.29)

0.06

 Concentric hypertrophy

31/144

1.27 (0.83, 1.96)

0.27

15/160

1.01 (0.56, 1.81)

0.98

 Eccentric hypertrophy

41/228

1.55 (1.08, 2.24)

0.02

29/240

1.55 (1.00, 2.41)

0.05

Female

      

 Normal geometry

153/3969

Reference

–

110/4012

Reference

–

 Concentric remodeling

33/397

1.36 (0.92, 2.01)

0.12

20/410

0.94 (0.57, 1.55)

0.81

 Concentric hypertrophy

36/215

1.58 (1.06, 2.36)

0.03

32/219

1.99 (1.29, 3.08)

 < 0.01

 Eccentric hypertrophy

51/496

1.27 (0.90, 1.79)

0.18

47/500

1.68 (1.16, 2.44)

 < 0.01

  1. Adjusted for age, sex, BMI, smoking, drinking, heart rate, history of CVD, SBP, DBP, TC, TG, LDL-C, HDL-C, FPG, medication for hypertension and diabetes, LAD, LVEF and E/A as appropriate